By Nathan Hale ( April 5, 2018, 8:38 PM EDT) -- Otsuka Pharmaceutical Co. Ltd. and Bristol-Myers Squibb Co. are looking to narrow one of three cases set for trial in multidistrict litigation over side effects of the antipsychotic drug Abilify, arguing the consumers' failure-to-warn claims are unsupported....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.